Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Secondary cancers, Small cell lung cancer
Closed
Phase 3
This trial is looking at adding lurbinectedin to atezolizumab to help treat small cell lung cancer (SCLC).
It is for people whose cancer has spread within the chest or to other parts of the body. This is called extensive disease.
Recruitment start: 17 November 2021
Recruitment end: 26 December 2023
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Dr Raffaele Califano
Roche
Last reviewed: 02 Jan 2024
CRUK internal database number: 18141
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
